Primrose Therapeutics is engaged in the development of treatments for polycystic kidney disease. Founded by Eric Rowinsky in 2010, Primrose Therapeutics is headquartered in New York.
FOUNDED:
2010
INDUSTRY:
Biotechnology, Medical, Therapeutics
FOUNDERS:
Eric Rowinsky
You are seconds away from signing up for the hottest list in New York Tech!
Join the millions and keep up with the stories shaping entrepreneurship. Sign up today.
